497 related articles for article (PubMed ID: 20077527)
41. Molecular cytogenetic analysis in splenic lymphoma with villous lymphocytes: frequent allelic imbalance of the RB1 gene but not the D13S25 locus on chromosome 13q14.
García-Marco JA; Nouel A; Navarro B; Matutes E; Oscier D; Price CM; Catovsky D
Cancer Res; 1998 Apr; 58(8):1736-40. PubMed ID: 9563492
[TBL] [Abstract][Full Text] [Related]
42. Lymph node hyperplasia: clonal chromosomal and genomic rearrangements. Report of two new cases and literature review.
Villa N; Redaelli S; Lissoni S; Saccheri F; Sala E; Crosti F; Dalprà L; Carrino V; Pioltelli P; Isimbaldi G
Cancer Genet; 2014; 207(1-2):12-8. PubMed ID: 24636528
[TBL] [Abstract][Full Text] [Related]
43. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
44. Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma.
Kim WS; Honma K; Karnan S; Tagawa H; Kim YD; Oh YL; Seto M; Ko YH
Genes Chromosomes Cancer; 2007 Aug; 46(8):776-83. PubMed ID: 17492759
[TBL] [Abstract][Full Text] [Related]
45. Typical genomic imbalances in primary MALT lymphoma of the orbit.
Matteucci C; Galieni P; Leoncini L; Lazzi S; Lauria F; Polito E; Martelli MF; Mecucci C
J Pathol; 2003 Aug; 200(5):656-60. PubMed ID: 12898603
[TBL] [Abstract][Full Text] [Related]
46. Follicular lymphoma with prominent Dutcher body formation: a pathologic study of 3 cases in comparison with nodal or splenic lymphoplasmacytic lymphoma and marginal zone lymphoma.
Wang E; Stoecker M; Burchette J; Rehder C
Hum Pathol; 2012 Nov; 43(11):2001-11. PubMed ID: 22607703
[TBL] [Abstract][Full Text] [Related]
47. Clonally related splenic marginal zone lymphoma and Hodgkin lymphoma with unmutated V gene rearrangements and a 15-yr time gap between diagnoses.
Rosenquist R; Roos G; Erlanson M; Küppers R; Bräuninger A; Hansmann ML
Eur J Haematol; 2004 Sep; 73(3):210-4. PubMed ID: 15287919
[TBL] [Abstract][Full Text] [Related]
48. Histopathologic features of splenic small B-cell lymphomas. A study of 42 cases with a definitive diagnosis by the World Health Organization classification.
Kansal R; Ross CW; Singleton TP; Finn WG; Schnitzer B
Am J Clin Pathol; 2003 Sep; 120(3):335-47. PubMed ID: 14502797
[TBL] [Abstract][Full Text] [Related]
49. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
50. Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis.
Mao X; Lillington D; Child F; Russell-Jones R; Young B; Whittaker S
Genes Chromosomes Cancer; 2002 Oct; 35(2):144-55. PubMed ID: 12203778
[TBL] [Abstract][Full Text] [Related]
51. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F
Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359
[TBL] [Abstract][Full Text] [Related]
52. Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Bonfiglio F; Bruscaggin A; Guidetti F; Terzi di Bergamo L; Faderl M; Spina V; Condoluci A; Bonomini L; Forestieri G; Koch R; Piffaretti D; Pini K; Pirosa MC; Cittone MG; Arribas A; Lucioni M; Ghilardi G; Wu W; Arcaini L; Baptista MJ; Bastidas G; Bea S; Boldorini R; Broccoli A; Buehler MM; Canzonieri V; Cascione L; Ceriani L; Cogliatti S; Corradini P; Derenzini E; Devizzi L; Dietrich S; Elia AR; Facchetti F; Gaidano G; Garcia JF; Gerber B; Ghia P; Gomes da Silva M; Gritti G; Guidetti A; Hitz F; Inghirami G; Ladetto M; Lopez-Guillermo A; Lucchini E; Maiorana A; Marasca R; Matutes E; Meignin V; Merli M; Moccia A; Mollejo M; Montalban C; Novak U; Oscier DG; Passamonti F; Piazza F; Pizzolitto S; Rambaldi A; Sabattini E; Salles G; Santambrogio E; Scarfò L; Stathis A; Stüssi G; Geyer JT; Tapia G; Tarella C; Thieblemont C; Tousseyn T; Tucci A; Vanini G; Visco C; Vitolo U; Walewska R; Zaja F; Zenz T; Zinzani PL; Khiabanian H; Calcinotto A; Bertoni F; Bhagat G; Campo E; De Leval L; Dirnhofer S; Pileri SA; Piris MA; Traverse-Glehen A; Tzankov A; Paulli M; Ponzoni M; Mazzucchelli L; Cavalli F; Zucca E; Rossi D
Blood; 2022 Feb; 139(5):732-747. PubMed ID: 34653238
[TBL] [Abstract][Full Text] [Related]
53. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
[TBL] [Abstract][Full Text] [Related]
54. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization.
Dierlamm J; Rosenberg C; Stul M; Pittaluga S; Wlodarska I; Michaux L; Dehaen M; Verhoef G; Thomas J; de Kelver W; Bakker-Schut T; Cassiman JJ; Raap AK; De Wolf-Peeters C; Van den Berghe H; Hagemeijer A
Leukemia; 1997 May; 11(5):747-58. PubMed ID: 9180302
[TBL] [Abstract][Full Text] [Related]
55. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
[TBL] [Abstract][Full Text] [Related]
56. Idelalisib and Rituximab in 17p Deletion-Positive Splenic Marginal Zone Lymphoma.
Philip AZ
J Natl Compr Canc Netw; 2018 Mar; 16(3):230-233. PubMed ID: 29523661
[TBL] [Abstract][Full Text] [Related]
57. The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.
Hockley SL; Else M; Morilla A; Wotherspoon A; Dearden C; Catovsky D; Gonzalez D; Matutes E
Br J Haematol; 2012 Aug; 158(3):347-54. PubMed ID: 22594855
[TBL] [Abstract][Full Text] [Related]
58. High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival.
Halldórsdóttir AM; Sander B; Göransson H; Isaksson A; Kimby E; Mansouri M; Rosenquist R; Ehrencrona H
Genes Chromosomes Cancer; 2011 Feb; 50(2):113-21. PubMed ID: 21117067
[TBL] [Abstract][Full Text] [Related]
59. [Relationship between p53 gene and chromosome 13q14 variations and prognosis in primary intestinal lymphoma].
Feng LJ; Zhang GP; Xie M; Cao PF; Fu CY; Hu ZL; Dai M
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):555-8. PubMed ID: 19650989
[TBL] [Abstract][Full Text] [Related]
60. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia.
Dickinson JD; Smith LM; Sanger WG; Zhou G; Townley P; Lynch JC; Pavletic ZS; Bierman PJ; Joshi SS
Br J Haematol; 2005 Feb; 128(4):460-71. PubMed ID: 15686453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
